Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Subsequent treatment should be initiated that is evidence-based ... grant (1S06023N); Fonds Wetenschappelijk Onderzoek, and ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

For millions of Americans, paying for the treatment needed to manage their diseases can become its own lifelong problem.

Studies have found that Black people may be disproportionately affected by colon cancer in the US, in part because of racism ...

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...